cephalexin has been researched along with Atypical Mycobacterial Infection, Disseminated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter-Ellul, LA; Martin, JE; Philips, RC; Wilkerson, MG | 1 |
| Armella, MA; Kevorkof, GV; Marticorena, BE; Micheli, ZA; Nigro, DR | 1 |
2 other study(ies) available for cephalexin and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Mycobacterium fortuitum infection arising in a new tattoo.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clarithromycin; Cosmetic Techniques; Drug Therapy, Combination; Humans; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Tattooing; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
[Nontuberculous mycobacteriosis. Report of 2 cases of infection by mycobacteria of the MAI (atypical Mycobacteria) group and its treatment with cephalosporins].
Topics: Antibiotics, Antitubercular; Cephalexin; Drug Therapy, Combination; Female; Humans; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sputum | 1987 |